Literature DB >> 26216564

Prenatal cocaine exposure and child outcomes: a conference report based on a prospective study from Cleveland.

Lynn T Singer1, Sonia Minnes1, Meeyoung O Min1, Barbara A Lewis1, Elizabeth J Short1.   

Abstract

OBJECTIVE: The study aims to describe developmental outcomes from a longitudinal prospective cohort (Cleveland study) of prenatally cocaine-exposed (CE) infants.
METHODS: Two hundred eighteen CE and 197 nonexposed infants were enrolled at birth and followed through mid-adolescence. Birth CE status was determined by interview and biologic measures. Multiple demographic, drug, and environmental correlates were controlled. Standardized, normative, reliable measures of fetal growth, intelligence quotient (IQ), behavior, executive function, and language were given at each age and risk for substance misuse assessed in adolescence. A subset of children received volumetric magnetic resonance imaging (MRI) at 7 years and functional MRI at 14 years. The effect of CE was determined through multiple regression analyses controlling for confounders.
RESULTS: Cocaine exposed had significant negative effects on fetal growth, attention, executive function, language, and behavior, while overall IQ was not affected. CE had significant negative effects on perceptual reasoning IQ and visual-motor skills and predicted lower volume of corpus callosum and decreased gray matter in the occipital and parietal lobes. CE children had higher risk for substance misuse. Confounding risk factors had additive effects on developmental outcomes.
CONCLUSIONS: Prenatal exposure to cocaine was related to poorer perceptual organization IQ, visual-spatial information processing, attention, language, executive function, and behavior regulation through early adolescence.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adolescent; behavior; cocaine; development; executive function; infant

Mesh:

Substances:

Year:  2015        PMID: 26216564      PMCID: PMC4595926          DOI: 10.1002/hup.2454

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  45 in total

Review 1.  Mechanisms of action of drugs of abuse on the developing fetal brain.

Authors:  C J Malanga; B E Kosofsky
Journal:  Clin Perinatol       Date:  1999-03       Impact factor: 3.430

2.  Prenatal cocaine exposure: drug and environmental effects at 9 years.

Authors:  Lynn T Singer; Suchitra Nelson; Elizabeth Short; Meeyoung O Min; Barbara Lewis; Sandra Russ; Sonia Minnes
Journal:  J Pediatr       Date:  2008-03-06       Impact factor: 4.406

3.  Effects of prenatal cocaine/polydrug use on maternal-infant feeding interactions during the first year of life.

Authors:  Sonia Minnes; Lynn T Singer; Robert Arendt; Sudtida Satayathum
Journal:  J Dev Behav Pediatr       Date:  2005-06       Impact factor: 2.225

Review 4.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

5.  Estimated effects of in utero cocaine exposure on language development through early adolescence.

Authors:  Emmalee S Bandstra; Connie E Morrow; Veronica H Accornero; Elana Mansoor; Lihua Xue; James C Anthony
Journal:  Neurotoxicol Teratol       Date:  2011 Jan-Feb       Impact factor: 3.763

6.  The effects of prenatal cocaine exposure on problem behavior in children 4-10 years.

Authors:  Sonia Minnes; Lynn T Singer; H Lester Kirchner; Elizabeth Short; Barbara Lewis; Sudtida Satayathum; Dyianweh Queh
Journal:  Neurotoxicol Teratol       Date:  2010-03-20       Impact factor: 3.763

7.  Infant neurobehavioral dysregulation: behavior problems in children with prenatal substance exposure.

Authors:  Barry M Lester; Daniel M Bagner; Jing Liu; Linda L LaGasse; Ronald Seifer; Charles R Bauer; Seetha Shankaran; Henrietta Bada; Rosemary D Higgins; Abhik Das
Journal:  Pediatrics       Date:  2009-10-12       Impact factor: 7.124

8.  Children's cognitive ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2008-07

9.  Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants.

Authors:  L T Singer; T S Yamashita; S Hawkins; D Cairns; J Baley; R Kliegman
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

10.  The effects of prenatal cocaine use on infant development.

Authors:  Gale A Richardson; Lidush Goldschmidt; Jennifer Willford
Journal:  Neurotoxicol Teratol       Date:  2007-12-28       Impact factor: 3.763

View more
  5 in total

1.  Developmental Outcomes of Infants Adopted from Foster Care: Predictive Associations from Perinatal and Preplacement Risk Factors.

Authors:  Irene Tung; Allison S Christian-Brandt; Audra K Langley; Jill M Waterman
Journal:  Infancy       Date:  2019-12-23

2.  Substance use and individual assets in urban adolescents: Subgroups and correlates in emerging adulthood.

Authors:  Meeyoung O Min; June-Yung Kim; Sonia Minnes; Sun-Kyung Kim; Devon Musson Rose; Lynn T Singer
Journal:  J Adolesc       Date:  2022-05-25

3.  The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use.

Authors:  Sonia Minnes; Meeyoung O Min; June-Yung Kim; Meredith W Francis; Adelaide Lang; Miaoping Wu; Lynn T Singer
Journal:  Drug Alcohol Depend       Date:  2017-03-24       Impact factor: 4.492

Review 4.  Effects of Fetal Substance Exposure on Offspring Substance Use.

Authors:  Neil C Dodge; Joseph L Jacobson; Sandra W Jacobson
Journal:  Pediatr Clin North Am       Date:  2019-12       Impact factor: 3.278

5.  Fatty acid ethyl esters in meconium and substance use in adolescence.

Authors:  Meeyoung O Min; Sonia Minnes; Hasina Momotaz; Lynn T Singer; Anna Wasden; Cynthia F Bearer
Journal:  Neurotoxicol Teratol       Date:  2020-12-23       Impact factor: 3.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.